PURPOSEAlzheimers disease (AD) is associated with cognitive impairment, brain atrophy, and elevated amyloid-beta (A{beta}) and tau. The study aimed to characterize regional atrophy associated with elevated A{beta} and tau, as measured by [{superscript 1} F]florbetapir (FBP) and [{superscript 1} F]flortaucipir (FTP) positron emission tomography (PET), respectively, and determine whether combining PET and atrophy data improves the prediction of cognitive impairment.
METHODSAlzheimers Disease Neuroimaging Initiative data (n = 381) were retrospectively analyzed. PET results were correlated with cortical thickness, gray matter (GM) volumes, Mini-Mental State Examination, and Montreal Cognitive Assessment. Linear/logistic regression and area under the curve (AUC) were used to evaluate for significant correlations and compare performances in distinguishing cognitive impairment, respectively.
Gonzales, M. et al. · CC-BY 4.0